Trial Profile
Landiolol for the prevention of atrial fibrillation in patients who have undergone a lobectomy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Feb 2014
Price :
$35
*
At a glance
- Drugs Landiolol (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 20 Feb 2014 New trial record